Stock Events

Stock Events

Aclaris Therapeutics (ACRS) Q1 2025 Earnings

27FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-1.01

-0.68

-0.34

-0.01

Details

Expected EPS

-0.286667

Actual EPS

-1.01

Surprise EPS

-0.72

Surprise Percent

+252.33%

Description

Aclaris Therapeutics (ACRS) has reported earnings of -1.01 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.